Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01682616
Brief Title: A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

First Submitted : June 26, 2012
First Submitted that Met QC Criteria : September 7, 2012
First Posted : September 11, 2012 (Estimate)

Last Update Submitted that Met QC Criteria : November 21, 2019
Last Update Posted : November 22, 2019